Immutrin Ltd
Research and experimental development on biotechnology · Cambridge
ActiveUnited KingdomIncorporated 2019Private Limited Company
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
0 without an end date · 4 ceasedNo control records without an end date are available. This alone does not establish who owns or controls the company.
Show 4 ceased records
Cambridge Innovation Capital LimitedCorporate
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%
Notified 2022-03-31 · Ceased 2026-02-10
Source record 190123694MP
Professor Mark Brian PepysIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%
Notified 2019-09-20 · Ceased 2022-03-31
Source record 185116365GW
Sir Gregory Paul WinterIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%
Notified 2019-09-20 · Ceased 2019-12-03
Source record 185116366DC
Daniel ChristIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%
Notified 2019-09-20 · Ceased 2019-12-03
Source record 185117881People behind the business
Current appointments and the wider business interests of each person.
Appointments
6 current · 2 historicalNS
Nihal SinhaCurrent director
Appointed 2026-02-02
AS
Alexander Jack Kellow Sinclair-WilsonCurrent director
Appointed 2026-02-02
JT
James Newman TopperCurrent director
Appointed 2026-02-02
SK
Sef KurstjensCurrent director
Appointed 2025-02-01 · 1 yr · Director
MT
Mihriban TunaCurrent director
Appointed 2024-02-06 · 2 yrs · Scientist
Show 2 historical appointments
GW
Gregory WinterResigned director
Resigned 2019-09-20 · 6 yrs · Retired Research Scientist
MP
Mark PepysResigned director
Resigned 2019-09-20 · 6 yrs · Company Director
Board profile
- People with appointments
- 6
- Directors assessed
- 6
- Median age
- 49
- Under 35
- 0
- 65 and over
- 0
- Disqualified match
- None active